We are live on ! Find out more
SC

Sessa Capital Portfolio holdings

AUM $5.98B
1-Year Est. Return 99.85%
This Fund
S&P 500
This Quarter Est. Return
-2.46%
1 Year Est. Return
+99.85%
3 Year Est. Return
+146.79%
5 Year Est. Return
+201.69%
10 Year Est. Return
+788.83%
AUM
$2.09B
AUM Growth
+$68.8M
Cap. Flow
-$149M
Cap. Flow %
-7.12%
Top 10 Hldgs %
72.78%
Holding
59
New
15
Increased
5
Reduced
8
Closed
16

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$223M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$123M
3
WBD icon
Warner Bros
WBD
+$35.9M
4
AIV
Aimco
AIV
+$26.5M
5
FLEX icon
Flex
FLEX
+$16.9M

Top Sells

Rank Stock Value
1
JXN icon
Jackson Financial
JXN
+$161M
2
WFC icon
Wells Fargo
WFC
+$146M
3
DTM icon
DT Midstream
DTM
+$102M
4
CTVA icon
Corteva
CTVA
+$95.2M
5
WW
WW International
WW
+$40.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.48%
2 Communication Services 20.22%
3 Materials 19.75%
4 Financials 8.42%
5 Healthcare 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
26
DELISTED
Apellis Pharmaceuticals
APLS
$7.57M 0.36%
+149,000
New +$6.58M
CLDX icon
27
Celldex Therapeutics
CLDX
$3.02B
$7.22M 0.35%
+212,000
New +$6.78M
ASND icon
28
Ascendis Pharma A/S
ASND
$15.8B
$6.87M 0.33%
+58,500
New +$6.78M
PRTA icon
29
Prothena Corp
PRTA
$428M
$6.84M 0.33%
+187,000
New +$6.74M
CRSP icon
30
CRISPR Therapeutics
CRSP
$5.01B
$6.78M 0.32%
+108,000
New +$6.78M
PTGX icon
31
Protagonist Therapeutics
PTGX
$9.28B
$6.09M 0.29%
+257,000
New +$7.24M
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.61B
$6.03M 0.29%
+249,000
New +$6.03M
TSVT
33
DELISTED
2seventy bio
TSVT
$5.82M 0.28%
341,302
-700
-0.2% -$11.9K
RCUS icon
34
Arcus Biosciences
RCUS
$3.1B
$5.71M 0.27%
+181,000
New +$6.06M
FPAC
35
DELISTED
Far Peak Acquisition Corporation
FPAC
$5.13M 0.25%
516,536
LKFT
36
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$5.09M 0.24%
82,000
CND
37
DELISTED
Concord Acquisition Corp.
CND
$4.97M 0.24%
500,000
VELO
38
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$3.91M 0.19%
400,650
AMPS
39
DELISTED
Altus Power
AMPS
$2.66M 0.13%
357,849
-108,709
-23% -$854K
MGNX icon
40
MacroGenics
MGNX
$257M
$2.16M 0.1%
+244,864
New +$2.7M
RXST icon
41
RxSight
RXST
$234M
$2.03M 0.1%
164,282
BHR
42
Braemar Hotels & Resorts
BHR
$128M
$160K 0.01%
25,951
ALLO icon
43
Allogene Therapeutics
ALLO
$594M
-334,396
Closed -$4.99M
BLUE
44
DELISTED
bluebird bio
BLUE
-45,616
Closed -$9.11M
LOGI icon
45
CALL
Logitech
LOGI
$14.5B
-248,500
Closed -$20.5M
LOGI icon
46
PUT
Logitech
LOGI
$14.5B
-777,300
Closed -$64.1M
SEAT icon
47
Vivid Seats
SEAT
$49.9M
-27,816
Closed -$6.05M
SOND
48
DELISTED
Sonder
SOND
-30,084
Closed -$6M
WFC icon
49
CALL
Wells Fargo
WFC
$271B
-1,383,100
Closed -$66.4M
WFC icon
50
Wells Fargo
WFC
$271B
-3,050,210
Closed -$146M

Similar funds

Sessa Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Sessa Capital held 59 positions worth $2.09B, up 3.4% from $2.02B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Sessa Capital withdrew a net $149M in Q1 2022, closing 16 positions and reducing 8 holdings. Its most notable exit was Wells Fargo, an estimated $146M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 16% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Sessa Capital opened a new position in Discovery, Inc. Series C Common Stock worth $113M.

  • Sessa Capital's largest Q1 2022 buy was Discovery, Inc. Series C Common Stock: 4,519,093 shares worth $113M.
  • Sessa Capital added most to AT&T in Q1 2022, an estimated $223M increase.
  • Sessa Capital's biggest Q1 2022 reduction was Jackson Financial, cutting an estimated $161M.
  • Sessa Capital fully exited Wells Fargo in Q1 2022, selling an estimated $146M.
  • Sessa Capital's ten largest holdings make up 73% of its $2.09B portfolio in Q1 2022.
  • Sessa Capital opened 15 new positions and closed 16 in Q1 2022.
  • Sessa Capital's portfolio value rose 3.4% quarter-over-quarter to $2.09B.

Based on Sessa Capital's 13F filing for Q1 2022, filed 16 May 2022.